Events - Pharmacy Technician Pulse

Study Reveals Robust Benefits of Semaglutide in Protecting Against Kidney, CV Events in Patients With T2D

Drug Topics

MAY 24, 2024

Semaglutide reduced the risk of major kidney disease and cardiovascular (CV) events, and death from any cause, while simultaneously decelerating the loss of kidney function, among patients with type 2 diabetes (T2D) and CKD compared to placebo.

Understanding Adverse Events With BCMA-, Non-BCMA-Targeting Bispecific Antibodies in Multiple Myeloma

Drug Topics

DECEMBER 13, 2023

Understanding the adverse event profile of bispecific antibodies can aid treatment selection and improve patient outcomes.

Flu Vaccine May Protect Against Heart Attack, Cardiovascular Events

Drug Topics

NOVEMBER 24, 2023

Study authors recommend that healthcare personnel consider prioritizing influenza vaccination for patients with recent cardiovascular diseases (CVDs) in light of new evidence.

Vaccines

Ascension reports systems, clinical operations disrupted amid apparent 'cybersecurity event'

Fierce Healthcare

MAY 8, 2024

Ascension disclosed Wednesday that it has detected “unusual activity” on some of its technology networks that it believes “is due to a cybersecurity event.” | The Catholic health giant said it detected "unusual activity" Wednesday and "immediately" activated remediation processes, including hiring a third-party cybersecurity firm. (..)

Adverse events increased after hospitals acquired by private equity, study finds

Fierce Healthcare

DECEMBER 27, 2023

A hospital’s acquisition by a private equity firm is linked to a rise in adverse events despite the pool of lower risk patients they tend to admit, according to a Medicare Part A claims analysis pu | Hospital-acquired adverse events among Medicare beneficiaries were 25% higher within the three years after a private equity acquisition compared to control (..)

Hospitals

STAT Virtual Event | 2024 JPM Recap, Live!

STAT

JANUARY 12, 2024

Editor’s note: A livestream of the event will be embedded below at 1 p.m. Relive this year’s J.P. Morgan Healthcare Conference with the STAT reporters who attended. Get a full rundown of the deals, data, and scuttlebutt and come away with the ideas and water-cooler chatter you need for the year ahead.

Better Prevention Strategies Rely on the Monitoring of Outpatient Adverse Drug Events

Pharmacy Times

JULY 17, 2024

Currently, limited data show the effect of adverse drug events in the outpatient setting.

COVID-19 Associated with Increased Risk of Cardiovascular Events

Drug Topics

OCTOBER 11, 2024

A study published in Arteriosclerosis, Thrombosis, and Vascular Biology found the risk of major adverse cardiac events was higher in patients hospitalized with COVID-19.

Hospitals

STAT Virtual Event | Cancer’s Breakthrough Engine

STAT

DECEMBER 18, 2023

Editor’s note: A livestream of the event will be embedded below at 1 p.m. Since the development of Gleevec two decades ago, precision cancer medicines have become a driving force in biotech and a source of hope for cancer patients. Read the rest…

STAT Virtual Event | Tomorrow’s Trailblazers in Science

STAT

APRIL 25, 2024

Editor’s note: A livestream of the event will be embedded below at 1 p.m. Each year, STAT chooses a new class of Wunderkinds, showcasing stars of science and medicine who are in the midst of launching their careers.

Diabetic Emergencies Led to Decreased Cardiovascular Events in Patients with Heart Failure

Drug Topics

OCTOBER 1, 2024

Researchers compared the cardiovascular outcomes of patients hospitalized for heart failure that did or did not experience diabetic emergencies.

Hospitals

COVID-19 Hospital Burden Associated With Increased Inpatient Adverse Events Among Patients With and Without COVID-19

Pharmacy Times

NOVEMBER 12, 2024

High COVID-19 hospital caseload strain led to increases in inpatient adverse events among patients both with and without SARS-CoV-2 infection.

Hospitals

Collaboration is critical to the future of healthcare, and events are the key to unlocking it

pharmaphorum

OCTOBER 8, 2024

Collaboration is essential for the future of healthcare, and events play a pivotal role in fostering it. Learn how collaboration can drive innovation in healthcare through impactful events.

Assessing Improvements to Reduce Insulin-Related Hypoglycemic Events | ASHP Midyear

Drug Topics

DECEMBER 10, 2024

Medication alerts, nurse education, and pharmacist interventions led to lower hypoglycemic events every year after they were implemented.

US Vaccine Adverse Event Reporting System Not Meeting Standards

Drug Topics

NOVEMBER 16, 2023

VAERS was designed to collect reports of symptoms, diagnoses, hospital admissions, and deaths after vaccination for postmarket safety signals.

Vaccines

Vaccines Hospitals

To approve Amgen's lung cancer med Imdelltra, FDA saw past 'large number' of missing adverse events

Fierce Pharma

AUGUST 13, 2024

When the FDA approved Amgen’s Imdelltra in May, the T-cell engager was hailed as a breakthrough for the treatment of small cell lung cancer (SCLC) and as the first DLL3-targeting therapy of potenti | In granting an accelerated approval to Amgen's first-in-class DLL3 bispecific Imdelltra, the FDA had to work through a “large number” of missing (..)

FDA

STAT Virtual Event: ASCO Recap, Live!

STAT

JUNE 5, 2024

Editor’s note: A livestream of the event will be embedded below at 1 p.m. S TAT’s reporters, strung-out from several days of ASCO madness, will take the virtual stage to share convention hall insights, predictions for the months ahead, and of course will take your audience questions live. Read the rest…

In-person, hybrid, or digital? State of pharma meetings and events in 2024

pharmaphorum

FEBRUARY 1, 2024

Explore the current state of pharmaceutical meetings and events in 2024, including the shift from in-person to virtual and hybrid formats. Discover how the industry is embracing diversity, equity, and inclusion in these gatherings.

STAT+: RaDonda Vaught, nurse who accidentally killed patient, to speak at CommonSpirit event on patient safety

STAT

MARCH 1, 2024

CommonSpirit Health is hosting an educational event this month featuring RaDonda Vaught, the Tennessee nurse who was criminally prosecuted for accidentally killing a patient by injecting the wrong medication.

Hospitals

STAT+: From Epic to FDA, all the leaders presenting at HHS’ invite-only AI in health care event

STAT

SEPTEMBER 17, 2024

Called “AI in Action: Transforming Health and Human Services,” the three-hour event is hosted by the federal health department. Federal health officials wrestling with when and how to use artificial intelligence will on Wednesday host an invitation-only meeting of AI leaders across industry, academia, and government.

Medical Schools

Medical Schools FDA Hospitals

STAT+: A primer on HELIOS-B, an enormous stock-moving event for Alnylam Pharmaceuticals

STAT

JUNE 20, 2024

The outcome of the HELIOS-B study — expected at the end of June or early July — is an enormous stock-moving event for Alnylam Pharmaceuticals. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox.

STAT Virtual Event | Navigating a New Era in Alzheimer’s Treatment

STAT

MAY 7, 2024

Editor’s note: A livestream of the event will be embedded below at 1 p.m. It took decades for scientists to come up with treatments that could slow the progression of Alzheimer’s disease. Now patients and physicians face a new challenge: actually getting the medicines to people who might benefit from them.

Supply chain resilience in pharma: Delivering consistency amidst global events

pharmaphorum

SEPTEMBER 19, 2024

Explore how the pharmaceutical industry is ensuring supply chain resilience to maintain consistency despite global events. Learn more about strategies and practices implemented to address challenges and ensure reliable delivery of pharmaceutical products.

STAT+: The biotech scoreboard for the second quarter: 32 stock-moving events to watch

STAT

APRIL 2, 2024

Here is STAT’s biotech scoreboard, our regular ledger of stock-moving biotech events, for the second quarter and middle of the year: Obesity catalysts, first. Danish drugmaker Zealand Pharma — yes, there’s another Danish drug maker in obesity — is developing a long-acting amylin analog called petrelintide.

STAT+: The biotech scorecard for the fourth quarter: 14 stock-moving events to watch

STAT

OCTOBER 2, 2024

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the fourth quarter: Rarely before has a large-cap biotech had so much riding on the outcome of a Phase 2 study as Amgen does with its obesity treatment MariTide , also known as AMG 133. Results are coming before the end of the year.

Tirzepatide Demonstrates Reduction in Sleep Apnea-Relate Events

Pharmacy Times

APRIL 18, 2024

Eli Lilly and Company will submit results of the study to support tirzepatide (Zepbound) for treatment of obstructive sleep apnea later this year.

Before the Big Event: AI-Enabled Remote Cardiac Monitoring Can Mitigate Stress-Related Cardiovascular Events

Pharmacy Times

DECEMBER 2, 2024

AI-enabled remote cardiac telemetry can help manage stress’s effects on high-risk populations.

Clinical Safety Data Show Switching Between Rituximab Biosimilars Does Not Increase Adverse Events

Pharmacy Times

NOVEMBER 21, 2024

There were 2 main types of switches, including switching to rituximab subcutaneous and switching among different intravenous rituximab treatments.

FDA Adds Delayed Gastric Emptying as Adverse Event on Semaglutide Label

Pharmacy Times

NOVEMBER 14, 2024

The label includes postmarking reports showing rare instances of pulmonary aspiration for patients undergoing procedures that require general anesthesia or deep sedation.

Labelling

Labelling FDA

STAT+: The biotech scorecard for the third quarter: 19 stock-moving events to watch

STAT

JULY 2, 2024

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter: Late last month, Alnylam Pharmaceuticals reported positive, top-line results from its HELIOS-B clinical trial testing vutrisiran in an increasingly common heart disease called ATTR-CM.

Fierce Pharma Asia—Merck-Curon bispecific deal; Legend's path forward; Missing adverse events in Amgen FDA filing

Fierce Pharma

AUGUST 16, 2024

A large number of missing adverse events in South Korea triggered a full-scale check-up during the FDA's review of Amgen's Imdelltra. . | Merck licensed a bispecific from a Chinese biotech with plans to target oncology and autoimmune diseases. Legend Biotech is taking a close at its business as M&A has emerged as an option.

FDA

Technology Tools Increase Patient Safety in the Pharmacy

Drug Topics

SEPTEMBER 18, 2023

From automated medication dispensing systems to telepharmacy services, technology can help reduce the risk of adverse patient events.

Medication Dispensing

Cocaine, Cannabis Use Significantly Increased Cardiovascular Events

Drug Topics

OCTOBER 2, 2024

In posters presented at the Heart Failure Society of America 2024 Annual Meeting, researchers assessed how substance use disorders impact cardiovascular outcomes.

Male birth control research wins audience over at STAT Madness event

STAT

MARCH 22, 2024

What happens when too many excellent, pioneering researchers enter a room? A little madness.

Triptans Associated With Adverse Events Across Organ Systems

Drug Topics

DECEMBER 17, 2024

Triptans are used to treat acute migraine and cluster headaches.

More than 60 researchers ask Congress to support innovation

PhRMA

JUNE 26, 2023

Earlier this month, 62 researchers from our member companies came to Washington, DC to meet with congressional offices during our annual fly-in event. This year included a record-breaking number of meetings — 145 over the course of the day.

What to Expect at Outcomes 2024 SYNC National Conference

Drug Topics

FEBRUARY 20, 2024

Drug Topics sat down with Jude Dieterman, CEO of Outcomes, to discuss the value and uniqueness of the company in the pharmacy market, what’s next on the horizon, and the upcoming event.

Managing Adverse Event Profiles for Three Bispecific Antibodies Approved for Lymphoma

Pharmacy Times

APRIL 5, 2024

These FDA-approved therapies are used to treat lymphoma after 2 or more lines of therapy and represent significant advancements in the treatment of lymphoma.

FDA

Patients With CKD, Hyperkalemia Have Higher Rates of Major Adverse Cardiovascular Events

Pharmacy Times

NOVEMBER 2, 2023

An analysis of the REVOLUTIONIZE II study data showed that there is an unmet need for long-term outpatient treatment of hyperkalemia in patients with CKD.

Experts Discuss Serious Adverse Events for GLP-1 Medications

Pharmacy Times

JUNE 23, 2024

Potential concerns surrounding GLP-include pancreatitis, pancreatic cancer, colorectal cancer, suicide and other phycological effects, and thyroid cancer.

How Daylight Saving Time Increases Overall Health Risks

Drug Topics

MARCH 13, 2024

Recent studies on daylight saving time’s association with increased health risks have heightened the debate on whether to observe the biannual event or switch to one universal time.

Diabetes Can Serve as Traumatic Stressor for Adolescents, Young Adults

Drug Topics

FEBRUARY 6, 2024

A new study found that over a quarter of participants with type 1 daiebets exhibited clinically relevant levels of posttraumatic stress symptoms related to a diabetes event that they experienced.

Phase 2 Study Demonstrates Oral Rilzabrutinib Reduces Loss of Control Events in Patients With Asthma

Pharmacy Times

MAY 22, 2024

According to the investigators, these findings support the investigation of rilzabrutinib in patients with asthma in a phase 3 trial program.

What I learned about ultra-processed foods from stuffing my face at the world’s leading food technology event

STAT

JULY 31, 2024

CHICAGO — “Buttery Biscuits & Hot Honey Gravy,” mushroom jerky, soy chicken nuggets, strawberry champagne donuts, plant-based frozen yogurt and buñuelos, white cheddar cheese puffs, chocolatey cookie dippers, egg-free Spanish cheesecake, plant-based chorizo-style empanadas … I was at the annual gathering of food (..)

Study Reveals Robust Benefits of Semaglutide in Protecting Against Kidney, CV Events in Patients With T2D

Understanding Adverse Events With BCMA-, Non-BCMA-Targeting Bispecific Antibodies in Multiple Myeloma

Trending Sources

Flu Vaccine May Protect Against Heart Attack, Cardiovascular Events

Ascension reports systems, clinical operations disrupted amid apparent 'cybersecurity event'

Adverse events increased after hospitals acquired by private equity, study finds

STAT Virtual Event | 2024 JPM Recap, Live!

Better Prevention Strategies Rely on the Monitoring of Outpatient Adverse Drug Events

COVID-19 Associated with Increased Risk of Cardiovascular Events

STAT Virtual Event | Cancer’s Breakthrough Engine

STAT Virtual Event | Tomorrow’s Trailblazers in Science

Diabetic Emergencies Led to Decreased Cardiovascular Events in Patients with Heart Failure

COVID-19 Hospital Burden Associated With Increased Inpatient Adverse Events Among Patients With and Without COVID-19

Collaboration is critical to the future of healthcare, and events are the key to unlocking it

Assessing Improvements to Reduce Insulin-Related Hypoglycemic Events | ASHP Midyear

US Vaccine Adverse Event Reporting System Not Meeting Standards

To approve Amgen's lung cancer med Imdelltra, FDA saw past 'large number' of missing adverse events

STAT Virtual Event: ASCO Recap, Live!

In-person, hybrid, or digital? State of pharma meetings and events in 2024

STAT+: RaDonda Vaught, nurse who accidentally killed patient, to speak at CommonSpirit event on patient safety

STAT+: From Epic to FDA, all the leaders presenting at HHS’ invite-only AI in health care event

STAT+: A primer on HELIOS-B, an enormous stock-moving event for Alnylam Pharmaceuticals

STAT Virtual Event | Navigating a New Era in Alzheimer’s Treatment

Supply chain resilience in pharma: Delivering consistency amidst global events

STAT+: The biotech scoreboard for the second quarter: 32 stock-moving events to watch

STAT+: The biotech scorecard for the fourth quarter: 14 stock-moving events to watch

Tirzepatide Demonstrates Reduction in Sleep Apnea-Relate Events

Before the Big Event: AI-Enabled Remote Cardiac Monitoring Can Mitigate Stress-Related Cardiovascular Events

Clinical Safety Data Show Switching Between Rituximab Biosimilars Does Not Increase Adverse Events

FDA Adds Delayed Gastric Emptying as Adverse Event on Semaglutide Label

STAT+: The biotech scorecard for the third quarter: 19 stock-moving events to watch

Fierce Pharma Asia—Merck-Curon bispecific deal; Legend's path forward; Missing adverse events in Amgen FDA filing

Technology Tools Increase Patient Safety in the Pharmacy

Cocaine, Cannabis Use Significantly Increased Cardiovascular Events

Male birth control research wins audience over at STAT Madness event

Triptans Associated With Adverse Events Across Organ Systems

More than 60 researchers ask Congress to support innovation

What to Expect at Outcomes 2024 SYNC National Conference

Managing Adverse Event Profiles for Three Bispecific Antibodies Approved for Lymphoma

Patients With CKD, Hyperkalemia Have Higher Rates of Major Adverse Cardiovascular Events

Experts Discuss Serious Adverse Events for GLP-1 Medications

How Daylight Saving Time Increases Overall Health Risks

Diabetes Can Serve as Traumatic Stressor for Adolescents, Young Adults

Phase 2 Study Demonstrates Oral Rilzabrutinib Reduces Loss of Control Events in Patients With Asthma

What I learned about ultra-processed foods from stuffing my face at the world’s leading food technology event

Stay Connected